Torelx
Tolerx to collaborate on first-in-class cancer antibody
December 2, 2010Research and Development Cancer, T cell, Torelx, monoclonal antibody
US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
